Fig. 8. The in vivo anticancer efficacies of MSN. (A) The body weight growth curves and (B) tumor growth curves of H-22 tumor-bearing mice in various therapeutic groups during the 16 days' experimental period. Indicated values were mean ± SD (n = 6). *P < 0.05, **P < 0.01 vs. DOX/MSN2. ##P < 0.01 vs. DOX/MSN5. (C) The photograph of excised tumors at day 16.
